I agree that this site is using cookies. You can find further informations here.
X
Seligson, Nathan D.
56  results:
Search for persons X
?
1

CYP3A5 influences oral tacrolimus pharmacokinetics and timi..:

Seligson, Nathan D. ; Zhang, Xunjie ; Zemanek, Mark C....
Frontiers in Pharmacology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Atezolizumab as the First Systemic Therapy Approved for Alv..:

Bergsma, Emilie J. ; Elgawly, Mariam ; Mancuso, David...
Annals of Pharmacotherapy.  58 (2023)  4 - p. 407-415 , 2023
Link: https://doi.org/10.1177/..
 
?
3

CDK4/6 and autophagy inhibitors synergize to suppress the g..:

Duah, Ernest ; Seligson, Nathan D. ; Persaud, Avinash K....
Molecular Carcinogenesis.  62 (2023)  8 - p. 1201-1212 , 2023
Link: https://doi.org/10.1002/..
 
?
4

Gene partners of the EWSR1 fusion may represent molecularly..:

Walker, Victoria ; Jin, Dexter X. ; Millis, Sherri Z....
Translational Oncology.  38 (2023)  - p. 101795 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Genome-wide CRISPR/Cas9 screen identifies etoposide respons..:

Nguyen, Nam H. K. ; Rafiee, Roya ; Tagmount, Abderrahmane...
Blood Advances.  7 (2023)  9 - p. 1769-1783 , 2023
Link: https://doi.org/10.1182/..
 
?
6

PARP1 and POLD2 as prognostic biomarkers for multiple myelo..:

Thomas, Melissa ; Li, Junan ; King, Kevan...
Haematologica.  108 (2023)  8 - p. 2155-2166 , 2023
Link: https://doi.org/10.3324/..
 
?
7

Comparison of variants in TPMT and NUDT15 between sequencin..:

Cook, Kelsey J. ; Grusauskas, Victoria ; Gloe, Lucy...
Clinical and Translational Science.  16 (2023)  8 - p. 1352-1358 , 2023
Link: https://doi.org/10.1111/..
 
?
8

Development of a Campus-Wide Community Service Initiative d..:

King, Kevan ; Davis, Hannah E. ; Moorman-Li, Robin..
Pharmacy.  10 (2022)  3 - p. 47 , 2022
Link: https://doi.org/10.3390/..
 
?
9

Drivers of genomic loss of heterozygosity in leiomyosarcoma..:

Seligson, Nathan D. ; Tang, Joy ; Jin, Dexter X....
npj Precision Oncology.  6 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
10

Key Considerations for Selecting a Genomic Decision Support..:

Cook, Kelsey J. ; Duong, Benjamin Q. ; Seligson, Nathan D....
Clinical Pharmacology & Therapeutics.  110 (2021)  3 - p. 555-558 , 2021
Link: https://doi.org/10.1002/..
 
?
11

UGT1A1 Guided Cancer Therapy: Review of the Evidence and Co..:

Nelson, Ryan S. ; Seligson, Nathan D. ; Bottiglieri, Sal...
Cancers.  13 (2021)  7 - p. 1566 , 2021
Link: https://doi.org/10.3390/..
 
?
12

Evaluation of the timing of MRSA PCR nasal screening: How l..:

Turner, Stephen C ; Seligson, Nathan D ; Parag, Bhavyata..
American Journal of Health-System Pharmacy.  78 (2021)  Supplement_2 - p. S57-S61 , 2021
Link: https://doi.org/10.1093/..
 
?
13

Multiscale-omic assessment of EWSR1-NFATc2 fusion positive ..:

Seligson, Nathan D. ; Maradiaga, Richard D. ; Stets, Colin M....
npj Precision Oncology.  5 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
14

Developing Drugs for Tissue‐Agnostic Indications: A Paradig..:

Seligson, Nathan D. ; Knepper, Todd C. ; Ragg, Susanne.
Clinical Pharmacology & Therapeutics.  109 (2020)  2 - p. 334-342 , 2020
Link: https://doi.org/10.1002/..
 
?
15

Convergence of therapy-induced senescence (TIS) and EMT in ..:

Faheem, Mir Mohd ; Seligson, Nathan D. ; Ahmad, Syed Mudabir...
Cell Death Discovery.  6 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
1-15